Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Capital Expenditure

: $-174.77 Mil (TTM As of Jun. 2023)

View and export this data going back to 2009. Start your Free Trial

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Aspen Pharmacare Holdings's cash flow for capital expenditures for the six months ended in Jun. 2023 was $-110 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2023 was $-174.77 Mil.

Aspen Pharmacare Holdings Capital Expenditure Historical Data

The historical data trend for Aspen Pharmacare Holdings's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Capital Expenditure

-245.66

-157.00

-246.60

-170.54

-169.70

Aspen Pharmacare Holdings Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Capital Expenditure																-102.21	-71.11	-99.09	-64.82	-109.95

Aspen Pharmacare Holdings Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-174.77 Mil.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHY) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

APN:South Africa

Address

Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF

Website

https://www.aspenpharma.com

Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Headlines

From GuruFocus

Value Idea Contest: Aspen Pharmacare

By Matthew Sipos Matthew Sipos • 03-17-2019

Aspiring for Aspen Pharmacare Holdings Ltd's Dividend: A Comprehensive Analysis

By GuruFocus Research • 09-21-2023